)
)
Bayer Investor Relations Material
Latest events
Q3 2024
Bayer
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Bayer AG
Access all reports
Segment Data
Access more data
Net sales by
Business area
Crop Science
Pharmaceuticals
Consumer Health
Enabling Functions and Consolidation
Other
Expenses by
Financials
Bayer AG operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The company researches, develops, manufactures, and markets prescription products primarily for the areas of cardiology and women's healthcare; and specialty therapeutics in the areas of oncology, hematology, and ophthalmology. It is also involved in developing over-the-counter medications and dietary supplements.
Key slides for Bayer AG
43rd Annual J.P. Morgan Healthcare Conference 2025
Bayer AG
Q3 2024
Bayer AG
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
BAYN
Country
🇩🇪 Germany